In clinical trials, logistics are the invisible backbone. From investigational medicinal products (IMPs) and ancillary supplies to temperature-controlled storage and timely distribution, each element must function with precision. But what happens when a link in the chain breaks?

Supply chain disruptions—caused by global events, vendor failures, regulatory hurdles, or logistical delays—can jeopardize timelines, budgets, and, most critically, patient safety. That’s why risk management and strong vendor partnerships are essential components of any successful clinical logistics strategy.

Why Clinical Logistics Demand a Risk-Based Approach

Unlike commercial supply chains, clinical logistics involve:

  • Variable demand and small batch sizes
  • Sensitive materials, such as biologics and temperature-controlled products
  • Strict timelines, often tied to patient dosing windows
  • Complex regulatory environments across multiple countries

Each of these factors increases the potential for disruption. A delayed shipment, mislabeled product, or customs hold can have cascading effects. That’s why sponsors must go beyond transactional vendor relationships and adopt a proactive, risk-based approach.

Key Risks in Clinical Supply Chains

Some of the most common risks include:

  • Vendor non-performance (e.g., delays, errors, or lack of flexibility)
  • Regulatory non-compliance during importation, labeling, or distribution
  • Temperature excursions and cold chain failures
  • Ineffective communication between vendors, sites, and sponsors
  • Single points of failure due to over-reliance on a single provider

Mitigating these risks starts with careful planning—and the right partners.

Building Strong Vendor Partnerships

Vendor selection is just the beginning. True collaboration is built through:

  1. Transparent Onboarding

Set clear expectations from the start, including deliverables, timelines, escalation procedures, and regulatory requirements. Conduct joint kickoff meetings to align goals.

  1. Defined Metrics and SLAs

Use KPIs and service level agreements to track performance. Regularly review them to identify early warning signs of issues.

  1. Ongoing Communication

Create a structured communication plan with check-ins, reports, and escalation paths. Strong relationships require continuous dialogue, not just reactive troubleshooting.

  1. Risk-Sharing Frameworks

Design contracts that account for shared responsibility and allow flexibility during unexpected disruptions. For example, dual-sourcing or backup depots can reduce dependency.

  1. Quality Audits and Reviews

Regular audits and vendor assessments are key to long-term success. Include vendors in lessons-learned reviews to promote a culture of continuous improvement.

Leveraging Risk Management Tools

Use formal tools like:

  • Risk registers to identify, rank, and address known risks
  • FMEAs (Failure Mode and Effects Analyses) for high-risk activities
  • Contingency planning to ensure backups for critical supply chain steps

A proactive risk management strategy transforms logistics from a potential bottleneck into a competitive advantage.

Final Thoughts

Clinical trials logistics are more complex. But by investing in strategic vendor partnerships and embedding risk management into every stage of your operations, you can build a resilient, responsive, and regulatory-compliant supply chain.

At IMP, we work with sponsors, CROs, and biotech companies to manage complex clinical supply logistics—offering expert importation, temperature-controlled storage, packaging, and distribution services tailored to your study needs.

📩 Have questions about how to strengthen your vendor network or mitigate supply risks? Contact us at [email protected]

 

Share this article

Risk Management and Vendor Partnerships in Clinical Trials Logistics: Building Resilient Supply Chains

Blog
From Contract to Collaboration: Navigating Vendor Management in Clinical Trials

We’re pleased to invite you to a short seminar Date: Wednesday, July 23rd, 2025 Time: 08:30–13:00 Location: Alon Hall, IMP Facility (SLE), Hate’ena 1 st., Modiin Region Industrial Park Waze: סלא טבע שוהם Join us for a focused and insightful seminar exploring the evolving landscape of vendor management in clinical trials — from oversight to strategic collaboration, from […]

Blog
Navigating 29C Importation in Israel

What is 29C Importation? Regulation 29C governs the importation of non-registered medicinal products into Israel under specific conditions. This regulation allows hospitals, healthcare providers, and sponsors to access treatments that are not locally registered but are essential for patient care. These imports often support clinical trials, compassionate use programs, or off-label treatments when no registered […]

Blog
Navigating Importation Regulations for Clinical Trials

Importing Investigational Medicinal Products (IMPs) and medical supplies for clinical trials is a complex and highly regulated process. Unlike standard commercial imports, clinical trial importation involves unique regulatory and logistical challenges that require specialized expertise. At IMP, we ensure a seamless and compliant importation process, working closely with regulatory authorities, customs officials, and shipping providers […]

Contact Us

    Back to top